242 related articles for article (PubMed ID: 26635032)
41. Immunoturbidimetric assay for estimating free light chains of immunoglobulins in urine and serum.
Tillyer CR; Iqbal J; Raymond J; Gore M; McIlwain TJ
J Clin Pathol; 1991 Jun; 44(6):466-71. PubMed ID: 1906071
[TBL] [Abstract][Full Text] [Related]
42. Light-chain paraproteins with lupus anticoagulant activity.
Yasin Z; Quick D; Thiagarajan P; Spoor D; Caraveo J; Palascak J
Am J Hematol; 1999 Oct; 62(2):99-102. PubMed ID: 10509004
[TBL] [Abstract][Full Text] [Related]
43. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain κ and λ to polyclonal antibody-based assays and immunofixation electrophoresis.
Drayson M; Carr-Smith H
Clin Chem Lab Med; 2012 Mar; 50(3):587-8. PubMed ID: 22505553
[No Abstract] [Full Text] [Related]
44. Serum immunoglobulin free light chains in patients with monoclonal gammapathies.
Lubimova NV; Turko TA; Votyakova OM; Kushlinskii NE
Bull Exp Biol Med; 2012 Jun; 153(2):249-54. PubMed ID: 22816095
[TBL] [Abstract][Full Text] [Related]
45. Urine immunofixation electrophoresis remains important and is complementary to serum free light chain.
Levinson SS
Clin Chem Lab Med; 2011 Nov; 49(11):1801-4. PubMed ID: 21663562
[TBL] [Abstract][Full Text] [Related]
46. [Evaluation of the usefulness of measuring the serum and urine levels of light chain immunoglobulins in multiple myeloma and Waldenström's macroglobulinemia].
Kraj M; Maj S; Rostkowska J
Acta Haematol Pol; 1991; 22(1):21-30. PubMed ID: 1823963
[TBL] [Abstract][Full Text] [Related]
47. Interpretation Difficulties of Serum Immunofixation Test in Immunoglobulin D Multiple Myeloma with Hidden Lambda Light Chains.
Biaz A; Uwingabiye J; Rachid A; Dami A; Bouhsain S; Ouzzif Z; Idrissi SEM
Clin Lab; 2018 Jun; 64(6):1065-1069. PubMed ID: 29945318
[TBL] [Abstract][Full Text] [Related]
48. Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study.
Tacchetti P; Pantani L; Patriarca F; Petrucci MT; Zamagni E; Dozza L; Galli M; Di Raimondo F; Crippa C; Boccadoro M; Barbato S; Tosi P; Narni F; Montefusco V; Testoni N; Spadano A; Terragna C; Pescosta N; Marzocchi G; Cellini C; Galieni P; Ronconi S; Gobbi M; Catalano L; Lazzaro A; De Sabbata G; Cangialosi C; Ciambelli F; Musto P; Elice F; Cavo M;
Lancet Haematol; 2020 Dec; 7(12):e861-e873. PubMed ID: 33242443
[TBL] [Abstract][Full Text] [Related]
49. The serological diagnostic challenges of multiple myeloma.
Gu Y; Hunter T; Offer M
Br J Hosp Med (Lond); 2015 Feb; 76(2):84-8. PubMed ID: 25671472
[TBL] [Abstract][Full Text] [Related]
50. Urine Protein Immunofixation Electrophoresis: Free Light Chain Urine Immunofixation Electrophoresis Is More Sensitive than Conventional Assays for Detecting Monoclonal Light Chains and Could Serve as a Marker of Minimal Residual Disease.
Singh G; Arinze N; Manthei DM; Plapp FV; Bollag RJ
Lab Med; 2023 Sep; 54(5):527-533. PubMed ID: 36857478
[TBL] [Abstract][Full Text] [Related]
51. Reference change values of M-protein, free light chain and immunoglobulins in monoclonal gammopathy.
Evliyaoglu O; van Helden J; Jaruschewski S; Imöhl M; Weiskirchen R
Clin Biochem; 2019 Dec; 74():42-46. PubMed ID: 31526775
[TBL] [Abstract][Full Text] [Related]
52. Turbidimetric measurement of Bence-Jones proteins using antibodies against free light chains of immunoglobulins. An artifact caused by different polymeric forms of light chains.
Heino J; Rajamäki A; Irjala K
Scand J Clin Lab Invest; 1984 Apr; 44(2):173-6. PubMed ID: 6426036
[TBL] [Abstract][Full Text] [Related]
53. Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients.
García de Veas Silva JL; Bermudo Guitarte C; Menéndez Valladares P; Rojas Noboa JC; Kestler K; Duro Millán R
PLoS One; 2016; 11(11):e0166841. PubMed ID: 27893836
[TBL] [Abstract][Full Text] [Related]
54. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.
Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA
Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572
[TBL] [Abstract][Full Text] [Related]
55. [IgD-lambda type multiple myeloma associated with IgG-kappa type benign monoclonal gammopathy].
Shimada H; Nishinarita S; Kishigami Y; Hayama T; Sawada U; Horie T; Nakamura N; Kato M; Hirano M; Nakamura O
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Apr; 18(2):235-40. PubMed ID: 7553059
[TBL] [Abstract][Full Text] [Related]
56. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.
Dispenzieri A; Kyle R; Merlini G; Miguel JS; Ludwig H; Hajek R; Palumbo A; Jagannath S; Blade J; Lonial S; Dimopoulos M; Comenzo R; Einsele H; Barlogie B; Anderson K; Gertz M; Harousseau JL; Attal M; Tosi P; Sonneveld P; Boccadoro M; Morgan G; Richardson P; Sezer O; Mateos MV; Cavo M; Joshua D; Turesson I; Chen W; Shimizu K; Powles R; Rajkumar SV; Durie BG;
Leukemia; 2009 Feb; 23(2):215-24. PubMed ID: 19020545
[TBL] [Abstract][Full Text] [Related]
57. Sharply increased serum free light-chain concentrations after treatment for multiple myeloma.
Murata K; Clark RJ; Lockington KS; Tostrud LJ; Greipp PR; Katzmann JA
Clin Chem; 2010 Jan; 56(1):16-8. PubMed ID: 20040623
[No Abstract] [Full Text] [Related]
58. [Usefulness of serum free light-chain assay for evaluation of therapeutic efficacy in non-secretory multiple myeloma].
Maruyama Y; Hayashi T; Ikeda H; Yasui H; Ishida T; Shinomura Y
Rinsho Ketsueki; 2013 Jan; 54(1):122-6. PubMed ID: 23391656
[TBL] [Abstract][Full Text] [Related]
59. [Measurement of serum free light chains and its clinical significance in 20 newly diagnosed patients of multiple myeloma].
Mao XB; Chen XQ; Zhai YP; Liang R; Gao GX; Ma GG; Yu YP; Li F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):829-32. PubMed ID: 18718070
[TBL] [Abstract][Full Text] [Related]
60. Biological variation of free light chains in serum.
Braga F; Infusino I; Dolci A; Panteghini M
Clin Chim Acta; 2013 Jan; 415():10-1. PubMed ID: 22981867
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
